Investigating N-arylpyrimidinamine (NAPA) compounds as early-stage inhibitors against human cytomegalovirus von Parsons, Andrea J., Ophir, Sabrina I., Gardner, Thomas J., Paredes, Jailene Casado, Stein, Kathryn R., Kwasny, Steven M., Cardinale, Steven C., Torhan, Matthew, Prichard, Mark N., James, Scott H., Atanasoff, Kristina E., G-Dayanandan, Narendran, Bowlin, Terry L., Opperman, Timothy J., Tortorella, Domenico

Volltext

[PRION + ] States Are Associated with Specific Histone H3 Post-Translational Modification Changes von Cobos, Samantha N, Janani, Chaim, Cruz, Gabriel, Rana, Navin, Son, Elizaveta, Frederic, Rania, Paredes Casado, Jailene, Khan, Maliha, Bennett, Seth A, Torrente, Mariana P

Volltext

The CD46 ectodomain participates in human cytomegalovirus infection of epithelial cells von Parsons, Andrea J., Stein, Kathryn R., Atanasoff, Kristina E., Ophir, Sabrina I., Casado, Jailene Paredes, Tortorella, Domenico

Volltext

Valspodar limits human cytomegalovirus infection and dissemination von Parsons, Andrea J., Cohen, Tobias, Schwarz, Toni M., Stein, Kathryn R., Ophir, Sabrina I., Casado, Jailene Paredes, Tortorella, Domenico

Volltext

N-arylpyrimidinamine (NAPA) compounds are broadly acting inhibitors of human cytomegalovirus infection and spread von Atanasoff, Kristina E, Ophir, Sabrina I, Parsons, Andrea J, Paredes Casado, Jailene, Lurain, Nell S, Bowlin, Terry L, Opperman, Timothy J, Tortorella, Domenico

Volltext